tiprankstipranks
Trending News
More News >
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315)
:2315
Hong Kong Market

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (2315) Dividend Date & History

Compare
1 Followers
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315) has no upcoming dividends

Other Large Cap Stocks Paying Dividends

Name
Dividend Yield
Smart Score
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Follow
$4.08 (6.83%)
$100.65B
10.00
+30.63%
3 Buy
3 Hold
2 Sell
Hold
$1.11 (4%)
$199.82B
17.05
+50.92%
15 Buy
3 Hold
0 Sell
Strong Buy
$0.65 (9.31%)
$675.49M
-0.51
-59.68%
0 Buy
1 Hold
1 Sell
Moderate Sell
$6.69 (2.39%)
$261.13B
48.33
+62.92%
7 Buy
5 Hold
2 Sell
Moderate Buy
$6.68 (4.57%)
$261.17B
17.15
-3.69%
10 Buy
6 Hold
2 Sell
Moderate Buy
$3.945 (3.11%)
$68.40B
11.63
+2.68%
13 Buy
11 Hold
0 Sell
Moderate Buy
$1.295 (7.34%)
$61.26B
13.44
+13.55%
8 Buy
1 Hold
0 Sell
Strong Buy
$2.763 (7.37%)
$8.09B
15.14
+6.94%
0 Buy
2 Hold
0 Sell
Hold
$1.92 (8.93%)
$14.92B
10.51
+4.42%
7 Buy
2 Hold
0 Sell
Strong Buy

FAQ

How much is Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H's dividend?
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315) does not pay a dividend
When is Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H ex-dividend date?
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315) does not pay a dividend.
When is Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H dividend payment date?
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315) does not pay a dividend.
Does Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H have sufficient earnings to cover their dividend?
The Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H has paid a dividend in the last year and may provide dividends in the near future.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis